Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Taiwan
  4. Taiwan Stock Exchange
  5. Adimmune Corporation
  6. Company
    4142   TW0004142005

ADIMMUNE CORPORATION

(4142)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.

Number of employees : 503 people.
Sales per Business
20192020Delta
Human Vaccine and Medicine1 299.69100%1 869.15100% +43.82%
TWD in Million
Sales per region
20192020Delta
Taiwan681.5752.4%1 292.0569.1% +89.57%
Others618.1247.6%577.1030.9% -6.64%
TWD in Million
Managers
Name Title Age Since
Chi Hsien Chan, Dr. Chairman & Chief Executive Officer - 2008
Chung Cheng Liu, Dr. President & Director - -
Chin Chuan Chang, Dr. Chief Operating Officer - 2004
Hsiao Po Hsu Independent Director - 2011
Mei Hsiang Ho, Dr. Independent Director - 2017
Yung Sheng Hsu, Dr. Independent Director - -
Fei Pan Chief Legal Officer & Spokesman - 2012
Hui Yi Lai Head-Accounting - -
Members of the board
Name Title Age Since
Chi Hsien Chan, Dr. Chairman & Chief Executive Officer - 2008
Chung Cheng Liu, Dr. President & Director - -
Hsiao Po Hsu Independent Director - 2011
Chien Fu Chen Director - 2017
Wei-Kuang Chi, Dr. Director - 2001
Mei Hsiang Ho, Dr. Independent Director - 2017
Ching Che Lin, Dr. Director - -
Mei Hsing Tseng Director - -
Chi Heng Lin, Dr. Director - -
Yung Sheng Hsu, Dr. Independent Director - -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 429,508,000 307,315,750 71.6% 0 0.0% 71.6%
Shareholders
NameEquities%
National Development Fund of The Executive Yuan 48,584,162 11.3%
Yucheng Management Consultant Co. Ltd. 37,100,000 8.64%
Johnson & Johnson 18,715,000 4.36%
Government of Taiwan 16,878,048 3.93%
The Vanguard Group, Inc. 9,998,284 2.33%
ADI Corp. 6,833,000 1.59%
Capital Investment Trust Corp. 5,809,001 1.35%
Sheng Mao Co-investment Co. Ltd. 4,033,850 0.94%
Mega Financial Holding Co., Ltd. 3,857,955 0.90%
Yu Chuan Cultural Investment Co. Ltd. 3,741,027 0.87%
Company contact information
Adimmune Corp.
3 Section 1, Tanxing Road
Tanzi District
Taichung, Taichung City 427 23

Phone : +886.4.25381220
Fax : +886.4.25382105
Web : http://www.adimmune.com.tw